DPYD and fluoropyrimidines: Using the data as our guide von Walko, Christine M.

Volltext

Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine von Seligson, Nathan D., Knepper, Todd C., Ragg, Susanne, Walko, Christine M.

Volltext

Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma von Bridge, Julia A., Sumegi, Janos, Druta, Mihaela, Bui, Marilyn M., Henderson-Jackson, Evita, Linos, Konstantinos, Baker, Michael, Walko, Christine M., Millis, Sherri, Brohl, Andrew S.

Volltext

Capecitabine: A review von Walko, Christine M., Lindley, Celeste

Volltext

Management of Common Adverse Events in Patients Treated With Sorafenib: Nurse and Pharmacist Perspective von Walko, Christine M, Grande, Carolyn

Volltext

Personalizing Medicine in Geriatric Oncology: Geriatric Oncology von WALKO, Christine M, MCLEOD, Howard L

Volltext

Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study von Sahebjam, Solmaz, Forsyth, Peter A, Tran, Nam D, Arrington, John A, Macaulay, Robert, Etame, Arnold B, Walko, Christine M, Boyle, Theresa, Peguero, Edwin N, Jaglal, Michael, Mokhtari, Sepideh, Enderling, Heiko, Raghunand, Natarajan, Gatewood, Tyra, Long, Wendy, Dzierzeski, Jennifer L, Evernden, Brittany, Robinson, Timothy, Wicklund, Melissa C, Kim, Sungjune, Thompson, Zachary J, Chen, Dung-Tsa, Chinnaiyan, Prakash, Yu, Hsiang-Hsuan Michael

Volltext

DPYD Testing: Time to Put Patient Safety First von Baker, Sharyn D, Bates, Susan E, Brooks, Gabriel A, Dahut, William L, Diasio, Robert B, El-Deiry, Wafik S, Evans, William E, Figg, William D, Hertz, Dan L, Hicks, J Kevin, Kamath, Suneel, Kasi, Pashtoon Murtaza, Knepper, Todd C, McLeod, Howard L, O'Donnell, Peter H, Relling, Mary V, Rudek, Michelle A, Sissung, Tristan M, Smith, D Max, Sparreboom, Alex, Swain, Sandra M, Walko, Christine M

Volltext

Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience von Knepper, Todd C., Bell, Gillian C., Hicks, J. Kevin, Padron, Eric, Teer, Jamie K., Vo, Teresa T., Gillis, Nancy K., Mason, Neil T., McLeod, Howard L., Walko, Christine M.

Volltext

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study von IRVIN, William J, WALKO, Christine M, RAAB, Rachel E, CORSO, Steven W, PEPPERCORN, Jeffrey M, ANDERSON, Steven M, FRIEDMAN, Kenneth J, OGBURN, Evan T, DESTA, Zeruesenay, FLOCKHART, David A, MCLEOD, Howard L, EVANS, James P, WECK, Karen E, CAREY, Lisa A, IBRAHIM, Joseph G, CHIU, WingK, DEES, E. Claire, MOORE, Susan G, OLAJIDE, Oludamilola A, GRAHAM, Mark L, CANALE, Sean T

Volltext

Regorafenib: A Novel Multitargeted Tyrosine Kinase Inhibitor for Colorectal Cancer and Gastrointestinal Stromal Tumors von Crona, Daniel J., Keisler, Meredith D., Walko, Christine M.

Volltext

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status von Wood, Anthony C, Zhang, Yonghong, Mo, Qianxing, Cen, Ling, Fontaine, Jacques, Hoffe, Sarah E, Frakes, Jessica, Dineen, Sean P, Pimiento, Jose M, Walko, Christine M, Mehta, Rutika

Volltext

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab von Chahoud, Jad, Skelton, 4th, William Paul, Spiess, Philippe E, Walko, Christine, Dhillon, Jasreman, Gage, Kenneth L, Johnstone, Peter A S, Jain, Rohit K

Volltext

The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer von Williams, Grant R., Deal, Allison M., Shachar, Shlomit Strulov, Walko, Christine M., Patel, Jai N., O’Neil, Bert, McLeod, Howard L., Weinberg, Marc S., Choi, Seul Ki, Muss, Hyman B., Sanoff, Hanna K.

Volltext

Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas von Fusco, Michael J., Piña, Yolanda, Macaulay, Robert J., Sahebjam, Solmaz, Forsyth, Peter A., Peguero, Edwin, Walko, Christine M.

Volltext

A Community‐Based Multicenter Trial of Pharmacokinetically Guided 5‐Fluorouracil Dosing for Personalized Colorectal Cancer Therapy von Patel, Jai N., O'Neil, Bert H., Deal, Allison M., Ibrahim, Joseph G., Sherrill, Gary B., Olajide, Oludamilola A., Atluri, Prashanti M., Inzerillo, John J., Chay, Christopher H., McLeod, Howard L., Walko, Christine M.

Volltext

Human Epidermal Growth Factor Receptor 2-Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues von Karan, Canan, Tan, Elaine, Sarfraz, Humaira, Knepper, Todd C, Walko, Christine M, Felder, Seth, Kim, Richard, Sahin, Ibrahim Halil

Volltext

Pharmacogenomic progress in individualized dosing of key drugs for cancer patients von McLeod, Howard, Walko, Christine M

Volltext

Novel and Expanded Oncology Drug Approvals of 2016-PART 1: New Options in Solid Tumor Management von Knepper, Todd C, Saller, James, Walko, Christine M

Volltext

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity von Hertz, Daniel L., Deal, Allison, Ibrahim, Joseph G., Walko, Christine M., Weck, Karen E., Anderson, Steven, Magrinat, Gustav, Olajide, Oludamilola, Moore, Susan, Raab, Rachel, Carrizosa, Daniel R., Corso, Steven, Schwartz, Garry, Graham, Mark, Peppercorn, Jeffrey M., Jones, David R., Desta, Zeruesenay, Flockhart, David A., Evans, James P., McLeod, Howard L., Carey, Lisa A., Irvin, William J.

Volltext